Oligo Chemist [Co-founder role]

[About ClearVision]

1^st RNA medicine to halt disease progression of genetic corneal diseases affecting millions.

We are in fundraising process and we know what diseases we will tackle first.

We are accepted into a university accelerator and have an option to take some funding.

Company One-Pager (Click Link to View)

[Vision]

Genetic corneal diseases affect millions of people worldwide and currently there are no therapeutic options for them.

At ClearVision, we are developing the 1^st RNA medicine to halt disease progression for millions of people suffering from genetic corneal diseases and we believe we can make a good impact on people’s life in the next decade.

[Team Profile]

Our team (1 founder + 3 advisors) has contributed to 3 transformative clinical trials including 1 FDA approved drug and 4 startups that were acquired for ~$2B.

Founder

https://www.linkedin.com/in/enping-qu-5314251a/

Please reach out to me on LinkedIn if interested.

[Who we are looking for]

An oligo chemist sharing our vision with ambition and expertise in oligo design and chemistry

• PhD; for non-PhD, demonstrate you are equally competent.
• Experience and skills in oligo (ASO, siRNA) design, screening, selection in vitro and in vivo
• Understand chemical modifications in ASO and siRNA and their impact on potency, safety.
• Knowledge of targeted delivery of oligo is desirable.
• Skills of bioconjugation is desirable.

[What we offer]

Co-founder role

Equity based compensation at the initial stage

Significant portion of the company ownership